Diagnostic testing for influenza: Review of current status and implications of newer treatment options

American Journal of Managed Care

Volumn 5, Issue 12, 1999, Pages 1555-1563

  Cram, Peter ^a   Blitz, Susan G ^a,b   Monto, Arnold ^c   Fendrick, A Mark ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c Univ of Michigan Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; HEMAGGLUTININ; OSELTAMIVIR; RIMANTADINE; SIALIDASE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; ZANAMIVIR;

COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; HUMAN; IMMUNOFLUORESCENCE; INFLUENZA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS CULTURE;

COST OF ILLNESS; DIAGNOSIS, DIFFERENTIAL; EDUCATION, MEDICAL, CONTINUING; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; INFLUENZA, HUMAN; LABORATORY TECHNIQUES AND PROCEDURES; ORTHOMYXOVIRIDAE; POLYMERASE CHAIN REACTION; UNITED STATES;

EID: 0033456282     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48:1-28.
2. Nicholson KG. Clinical features of influenza. Semin Respir Infect 1992;7:26-37.
3. Von Itzstein M, Wu MY, Kok GB, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993;363:418-423.
4. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Randomized trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B infections. Lancet 1998;352(9144):1877-1881.
5. Monto AS, Robinson DP, Herlocher ML, Hinson JJ, Elliott JM, Crisp A. Zanamivir in the prevention of influenza among healthy adults. JAMA 1999;282:31-35.
6. Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336-1343.
7. Lui K-J, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 1987;77:712-716.
8. Nichol KL, Margolis KL, Wuorenma J. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-806.
9. Neuzil KM, Reed GW, Mitchel EF Jr, Griffin MR. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999;281:901-907.
10. Monto AS. Influenza: Quantifying morbidity and mortality. Am J Med 1987;82(suppl 6A):20-25.
11. Nichol KL, Lind A, Margolis KL. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995;333:889-993.
12. Meltzer Ml, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: Priorities for intervention. Emerg Infect Dis 1999;5:659-671.
13. Gondahl B, Puppe W, Hoppe A, Huhne I, Weigl JA, Schmitt HJ. Rapid identification of 9 microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: Feasibility study. J Clin Microbiol 1999;37:1-7.
14. Doller G, Schuy W, Tjhen KY, Stekeler B, Gerth HJ. Direct detection of influenza virus antigen in nasopharyngeal specimens by direct enzyme immunoassay in comparison with quantitating virus shedding. J Clin Microbiol 1992;30:866-869.
15. Reina J, Munar M, Blanco I. Evaluation of a direct immunofluorescence assay, dot-blot enzyme immunoassay, and shell viral culture in the diagnosis of lower respiratory tract infections caused by influenza A virus. Diagn Microbiol Infect Dis 1996;25:143-145.
16. Daisy JA, Lief FS, Friedman HM. Rapid diagnosis of influenza A infection by direct immunofluorescence of nasopharyngeal aspirates in adults. J Clin Microbiol 1979;9:688-692.
17. Leonardi GP, Leib H, Birkhead GS, Smith C, Costello P, Conron W. Comparison of rapid detection methods for influenza A and their value in health-care management of institutionalized geriatric patients. J Clin Microbiol 1994;32:70-74.
18. Cherian T, Bobo L, Steinhoff MC, Karron RA, Yolken RH. Use of PCR-EIA for identification for influenza A virus matrix RNA in clinical samples negative for cultivable virus. J Clin Microbiol 1994;32:623-628.
19. Ellis JS, Fleming DM, Zambon MC. Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996. J Clin Microbiol 1997;35:2076-2082.
20. Pregliasco F, Mensi C, Casmorli L, Anselmi G. Comparison of RT-PCR with other diagnostic assays for rapid detection of influenza viruses. J Med Virol 1998;56:168-173.
21. Douglas RG Jr. Prophylaxis and treatment of influenza. N Engl J Med 1990;322:443-450.
22. Govaert TM, Dinant GJ, Aretz K, Knottnerus JA. The predictive value of influenza symptomatology in elderly people. Fam Pract 1998;15:16-22.
23. Carrat F, Tachet A, Rouzioux C, Housset B, Valleron A-J. Evaluation of clinical case definitions of influenza: Detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis 1999;28:283-290.
24. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999;130:397-403.
25. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: A randomized trial. JAMA 1999;281:908-913.
26. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998;158:1769-1776.
27. Keech M, Scott AJ, Ryan PJ. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med 1998;48(2):85-90.